![PDF] Diagnostic Approach to Gastroesophageal Reflux Disease: The Role of GERD Questionnaire and PPI Test | Semantic Scholar PDF] Diagnostic Approach to Gastroesophageal Reflux Disease: The Role of GERD Questionnaire and PPI Test | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/14676643510028c41ae888193c3dd206c43b137f/6-Figure3-1.png)
PDF] Diagnostic Approach to Gastroesophageal Reflux Disease: The Role of GERD Questionnaire and PPI Test | Semantic Scholar
![PDF] Modified Helicobacter test using a new test meal and a 13C-urea breath test in Helicobacter pylori positive and negative dyspepsia patients on proton pump inhibitors | Semantic Scholar PDF] Modified Helicobacter test using a new test meal and a 13C-urea breath test in Helicobacter pylori positive and negative dyspepsia patients on proton pump inhibitors | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ad314cd06cefa9454bb85c6b08864df949d5fffa/4-Figure1-1.png)
PDF] Modified Helicobacter test using a new test meal and a 13C-urea breath test in Helicobacter pylori positive and negative dyspepsia patients on proton pump inhibitors | Semantic Scholar
![The patient with refractory gastroesophageal reflux disease - Richter - 2006 - Diseases of the Esophagus - Wiley Online Library The patient with refractory gastroesophageal reflux disease - Richter - 2006 - Diseases of the Esophagus - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1397bdcf-93bd-4b2f-a503-e180107231a0/dote_619_f1.gif)
The patient with refractory gastroesophageal reflux disease - Richter - 2006 - Diseases of the Esophagus - Wiley Online Library
![Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial | The BMJ Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial | The BMJ](https://www.bmj.com/content/bmj/372/bmj.m4903/F1.medium.jpg)
Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial | The BMJ
![PDF] Diagnostic Approach to Gastroesophageal Reflux Disease: The Role of GERD Questionnaire and PPI Test | Semantic Scholar PDF] Diagnostic Approach to Gastroesophageal Reflux Disease: The Role of GERD Questionnaire and PPI Test | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/14676643510028c41ae888193c3dd206c43b137f/6-Figure4-1.png)
PDF] Diagnostic Approach to Gastroesophageal Reflux Disease: The Role of GERD Questionnaire and PPI Test | Semantic Scholar
Peripheral ischemic reserve in sepsis and septic shock as a new bedside prognostic enrichment tool: A Brazilian cohort study | PLOS ONE
![PDF] Diagnostic Approach to Gastroesophageal Reflux Disease: The Role of GERD Questionnaire and PPI Test | Semantic Scholar PDF] Diagnostic Approach to Gastroesophageal Reflux Disease: The Role of GERD Questionnaire and PPI Test | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/14676643510028c41ae888193c3dd206c43b137f/7-Figure5-1.png)
PDF] Diagnostic Approach to Gastroesophageal Reflux Disease: The Role of GERD Questionnaire and PPI Test | Semantic Scholar
![Many Patients Continue Using Proton Pump Inhibitors After Negative Results From Tests for Reflux Disease - Clinical Gastroenterology and Hepatology Many Patients Continue Using Proton Pump Inhibitors After Negative Results From Tests for Reflux Disease - Clinical Gastroenterology and Hepatology](https://www.cghjournal.org/cms/asset/80a36ccf-d1aa-4895-b0b3-89c9eafdcda5/gr1.jpg)
Many Patients Continue Using Proton Pump Inhibitors After Negative Results From Tests for Reflux Disease - Clinical Gastroenterology and Hepatology
![Reduction of the long-term use of proton pump inhibitors by a patient-oriented electronic decision support tool (arriba-PPI): study protocol for a randomized controlled trial | Trials | Full Text Reduction of the long-term use of proton pump inhibitors by a patient-oriented electronic decision support tool (arriba-PPI): study protocol for a randomized controlled trial | Trials | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13063-019-3728-2/MediaObjects/13063_2019_3728_Fig1_HTML.png)
Reduction of the long-term use of proton pump inhibitors by a patient-oriented electronic decision support tool (arriba-PPI): study protocol for a randomized controlled trial | Trials | Full Text
![Frontiers | Effects of Proton Pump Inhibitor Therapy, H. pylori Infection and Gastric Preneoplastic Pathology on Fasting Serum Gastrin Concentrations Frontiers | Effects of Proton Pump Inhibitor Therapy, H. pylori Infection and Gastric Preneoplastic Pathology on Fasting Serum Gastrin Concentrations](https://www.frontiersin.org/files/Articles/741887/fendo-12-741887-HTML/image_m/fendo-12-741887-g001.jpg)
Frontiers | Effects of Proton Pump Inhibitor Therapy, H. pylori Infection and Gastric Preneoplastic Pathology on Fasting Serum Gastrin Concentrations
![Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease - The Lancet Rheumatology Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease - The Lancet Rheumatology](https://www.thelancet.com/cms/attachment/b600229c-4b85-4f67-bc4a-17c8eeadb3d9/gr1_lrg.jpg)
Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease - The Lancet Rheumatology
![Value of pH Impedance Monitoring While on Twice-Daily Proton Pump Inhibitor Therapy to Identify Need for Escalation of Reflux Management - ScienceDirect Value of pH Impedance Monitoring While on Twice-Daily Proton Pump Inhibitor Therapy to Identify Need for Escalation of Reflux Management - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0016508521032388-fx1.jpg)